Silvio Ofner

1.0k total citations
28 papers, 839 citations indexed

About

Silvio Ofner is a scholar working on Molecular Biology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Silvio Ofner has authored 28 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Organic Chemistry and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Silvio Ofner's work include Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Silvio Ofner is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (6 papers), Receptor Mechanisms and Signaling (6 papers) and Neuropeptides and Animal Physiology (6 papers). Silvio Ofner collaborates with scholars based in Switzerland, Germany and United States. Silvio Ofner's co-authors include Peter J. Flor, Siem J. Veenstra, Herman van der Putten, Rainer Kühn, Kevin H. McAllister, John F. Cryan, Walter Schilling, Joachim Nozulak, Cédric Mombereau and Snežana Lukić and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Silvio Ofner

28 papers receiving 813 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silvio Ofner Switzerland 18 449 425 199 135 119 28 839
Emmanuel Pinard Switzerland 20 545 1.2× 321 0.8× 168 0.8× 385 2.9× 110 0.9× 44 1.3k
Wei Lemaire United States 16 784 1.7× 881 2.1× 189 0.9× 122 0.9× 73 0.6× 25 1.2k
Nigel Austin United Kingdom 14 329 0.7× 253 0.6× 134 0.7× 165 1.2× 89 0.7× 24 727
Pauline Carter United States 17 316 0.7× 473 1.1× 332 1.7× 46 0.3× 127 1.1× 20 1.2k
Claire M. Scott United Kingdom 14 370 0.8× 417 1.0× 148 0.7× 95 0.7× 78 0.7× 22 700
Michael W. Scherz United States 15 357 0.8× 177 0.4× 431 2.2× 128 0.9× 366 3.1× 25 1.1k
Peter A. Boxer United States 21 447 1.0× 454 1.1× 206 1.0× 309 2.3× 37 0.3× 34 1.3k
Curt A. Dvorak United States 19 536 1.2× 182 0.4× 269 1.4× 413 3.1× 218 1.8× 37 1.3k
Judit Sóvágó Sweden 18 400 0.9× 730 1.7× 334 1.7× 41 0.3× 69 0.6× 34 1.5k
Michael S. Hadley United Kingdom 16 472 1.1× 277 0.7× 118 0.6× 494 3.7× 88 0.7× 55 1.0k

Countries citing papers authored by Silvio Ofner

Since Specialization
Citations

This map shows the geographic impact of Silvio Ofner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvio Ofner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvio Ofner more than expected).

Fields of papers citing papers by Silvio Ofner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvio Ofner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvio Ofner. The network helps show where Silvio Ofner may publish in the future.

Co-authorship network of co-authors of Silvio Ofner

This figure shows the co-authorship network connecting the top 25 collaborators of Silvio Ofner. A scholar is included among the top collaborators of Silvio Ofner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvio Ofner. Silvio Ofner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jahnke, Wolfgang, Guido Bold, Andreas L. Marzinzik, et al.. (2015). A General Strategy for Targeting Drugs to Bone. Angewandte Chemie International Edition. 54(48). 14575–14579. 22 indexed citations
2.
Gutmann, Sascha, Alexandra Hinniger, Gabriele Fendrich, et al.. (2015). The Crystal Structure of Cancer Osaka Thyroid Kinase Reveals an Unexpected Kinase Domain Fold. Journal of Biological Chemistry. 290(24). 15210–15218. 14 indexed citations
3.
Jahnke, Wolfgang, Guido Bold, Andreas L. Marzinzik, et al.. (2015). Gezielte Anreicherung von Wirkstoffen am Knochen am Beispiel von allosterischen FPPS‐Inhibitoren. Angewandte Chemie. 127(48). 14783–14787. 2 indexed citations
4.
Marzinzik, Andreas L., René Amstutz, Guido Bold, et al.. (2015). Discovery of Novel Allosteric Non‐Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead Finding. ChemMedChem. 10(11). 1884–1891. 24 indexed citations
5.
Gee, Christine E., Daniel Peterlik, Rochdi Bouhelal, et al.. (2014). Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior. Journal of Biological Chemistry. 289(16). 10975–10987. 64 indexed citations
6.
Vranesic, Ivo, Silvio Ofner, Peter J. Flor, et al.. (2014). AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: Identification, SAR and pharmacological characterization. Bioorganic & Medicinal Chemistry. 22(21). 5790–5803. 46 indexed citations
7.
Hoyer, Daniël, Markus Fendt, Laura H. Jacobson, et al.. (2013). Distinct effects of IPSU and suvorexant on mouse sleep architecture. Frontiers in Neuroscience. 7. 235–235. 35 indexed citations
8.
Callander, Gabrielle E., Daniel Langenegger, Claudia Betschart, et al.. (2013). Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors. Frontiers in Neuroscience. 7. 230–230. 33 indexed citations
9.
Betschart, Claudia, Samuel Hintermann, Dirk Behnke, et al.. (2013). Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia. Journal of Medicinal Chemistry. 56(19). 7590–7607. 86 indexed citations
10.
Orain, David, Silvio Ofner, Manuel Koller, et al.. (2011). 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(2). 996–999. 16 indexed citations
11.
Koller, Manuel, Kurt Lingenhoehl, Markus Schmutz, et al.. (2011). Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity. Bioorganic & Medicinal Chemistry Letters. 21(11). 3358–3361. 33 indexed citations
12.
13.
Mitsukawa, Kayo, Silvio Ofner, Joachim Nozulak, et al.. (2005). A selective metabotropic glutamate receptor 7 agonist: Activation of receptor signaling via an allosteric site modulates stress parametersin vivo. Proceedings of the National Academy of Sciences. 102(51). 18712–18717. 204 indexed citations
14.
Vassout, A., Siem J. Veenstra, Kathleen Hauser, et al.. (2000). NKP608: a selective NK-1 receptor antagonist with anxiolytic-like effects in the social interaction and social exploration test in rats. Regulatory Peptides. 96(1-2). 7–16. 43 indexed citations
15.
Auberson, Yves P., Pierre Acklin, Serge Bischoff, et al.. (1999). N-Phosphonoalkyl-5-aminomethylquinoxaline-2,3-diones: In vivo active AMPA and NMDA(glycine) antagonists. Bioorganic & Medicinal Chemistry Letters. 9(2). 249–254. 28 indexed citations
16.
Acklin, Pierre, Hans Allgeier, Yves P. Auberson, et al.. (1998). 5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(5). 493–498. 21 indexed citations
17.
Auberson, Yves P., Pierre Acklin, Hans Allgeier, et al.. (1998). 5-aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists. Bioorganic & Medicinal Chemistry Letters. 8(1). 71–74. 19 indexed citations
18.
Pozza, Mario F., et al.. (1998). The potency of the novel tachykinin receptor antagonist CGP49823 at rat and gerbil motoneurones in vitro. European Journal of Pharmacology. 342(2-3). 203–208. 3 indexed citations
19.
Leenders, Klaus L., Angelo Antonini, J. Locher, et al.. (1993). Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET). European Journal of Clinical Pharmacology. 44(2). 135–140. 7 indexed citations
20.
Ofner, Silvio, et al.. (1981). Aufbau der Ligandsysteme des C, D‐Tetradehydrocorrins und Isobakteriochlorins durch Sulfidkontraktion. Kurzmitteilung. Helvetica Chimica Acta. 64(5). 1431–1443. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emmanuel Pinard Breakdown of academic impact, for papers by Wei Lemaire Breakdown of academic impact, for papers by Nigel Austin Breakdown of academic impact, for papers by Pauline Carter Breakdown of academic impact, for papers by Claire M. Scott Breakdown of academic impact, for papers by Michael W. Scherz Breakdown of academic impact, for papers by Peter A. Boxer Breakdown of academic impact, for papers by Curt A. Dvorak Breakdown of academic impact, for papers by Judit Sóvágó Breakdown of academic impact, for papers by Michael S. Hadley
Rankless by CCL
2026